Johnson & Johnson
JNJ
#21
Rank
A$1.009 T
Marketcap
A$419.33
Share price
-1.12%
Change (1 day)
37.26%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): A$9.76

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is A$9.91. In 2025 the company made an earnings per share (EPS) of A$16.53 an increase over its 2024 EPS that were of A$9.93.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$9.76-40.97%
2025A$16.5366.46%
2024A$9.93-53.6%
2023A$21.40111.16%
2022A$10.14-13.84%
2021A$11.7641.81%
2020A$8.30-18.92%
2019A$10.2321.2%
2018A$8.441125.3%
2017A$0.69-92.23%
2016A$8.867.37%
2015A$8.26-4.16%
2014A$8.6118.1%
2013A$7.2924.88%
2012A$5.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.79-21.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.05-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.01-59.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$6.06-38.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$45.85 362.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.94-70.35%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
A-$4.60-146.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$14.02 41.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.47-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.27-56.92%๐Ÿ‡ฌ๐Ÿ‡ง UK